Salzman & Co’s Pfizer PFE Stock Holding History

Salzman & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,576	Closed	-$105K	–	17
2014 Q4	$105K	Buy	+3,576	New	+$103K	0.02%	17

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Salzman & Co's PFE Position: Q1 2015 in Review

Salzman & Co sold out of Pfizer (PFE) in Q1 2015, closing a stake of 3,576 shares — an estimated $105K sold.

Salzman & Co first reported a position in PFE in Q4 2014 and held it in 1 quarter. The position peaked at $105K in Q4 2014. 1,874 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

Salzman & Co reported no remaining Pfizer position as of Q1 2015 after selling out during the quarter.
Salzman & Co sold 3,576 Pfizer shares in Q1 2015, an estimated $105K.
Salzman & Co first reported a position in Pfizer in Q4 2014 and held it in 1 quarter.
Salzman & Co's Pfizer position peaked at $105K in Q4 2014.
1,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Salzman & Co's 13F filing for Q1 2015, filed 14 May 2015.